Growth inhibition by microRNAs that target the insulin receptor substrate-1

Cell Cycle

Volumn 8, Issue 14, 2009, Pages 2255-2259

  La Rocca, Gaspare ^a   Shi, Bin ^a,b   Badin, Margherita ^a   De Angelis, Tiziana ^a   Sepp Lorenzino, Laura ^b   Baserga, Renato ^a,c  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c Bluemle Life Sciences Building ^*  (United States)

Author keywords

Cellular growth; IGF 1R pathway; MicroRNA; Non codingRNA; Tumor suppression

Indexed keywords

INSULIN RECEPTOR SUBSTRATE 1; MICRORNA; SOMATOMEDIN C;

ARTICLE; CANCER INHIBITION; CELL DEATH; CELL GROWTH; CONTROLLED STUDY; DOWN REGULATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; PROTEIN TARGETING; SIGNAL TRANSDUCTION;

EID: 68049109358     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.8.14.9026     Document Type: Article

References (37)

1. Michael MZ, O'Connor SM, van Host Pellekaan NG, Young GP, James RJ. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 2003; 1:882-891
2. Iorio MV, Ferracin M, Liu CG, Verones A, Spizzo R, Sabbioni S, et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005; 65:7065-7070 (Pubitemid 41161233)
3. Kent OA, Mendell JT. A small piece in the cancer puzzle: microRNAs at tumor suppressors and oncogenes. Oncogene 2006; 25:6188-6196
4. Cummins JM, He Y, Leary RJ, Pagliarini R, Diaz LA Jr, Sjoblom T, et al. The colorectal microRNAome. Proc Natl Acad Scie 2006; 103:3687-3692
5. Bandres E, Cubedo E, Agirre X, Malumbres R, Zarate R, Ramirez N, et al. Identification by real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer 2006; 19:5-29. (Pubitemid 44264064)
6. Calin GA, Croce CM. MicroRNA-cancer connection: the beginning of a new tale. Cancer Res 2006; 66:7390-7394
7. Shi B, Sepp-Lorenzino M, Prisco M, Linsley P, deAngelis T, Baserga R. Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells. J Biol Chem 2007; 282:32582-32590 (Pubitemid 350159311)
8. Larsson O, Girnita A, Girnita L. Role of insulin-like growth factor receptor signaling in cancer. Brit J Cancer 2007; 92:2097-2101
9. Baserga R. The insulin receptor substrate-1: a biomarker for cancer? Exp Cell Res 2009; 315:727-732
10. LaRocca G, Badin M, Shi B, Xiu S-Q, DeAngelis T, Sepp-Lorenzino L, Baserga R. Mechanism of growth inhibition by microRNA 145: the role of the IGF-1 receptor signaling pathway. J Cell Physiol 2009; In press.
11. Baserga R. The contradictions of the insulin-like growth factor 1 receptor. Oncogene 2000; 19:5574-5581
12. Fazi F, Rosa A, Fatica A, Gelmetti V, DeMarchis ML, Nervi C, Bozzoni I. A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPα regulates human granulopoiesis. Cell 2005; 123:819-831 (Pubitemid 41721029)
13. Shi B, Prisco M, Calin G, Liu C-g, Russo G, Giordano A, Baserga R. Expression profiles of micro RNA in proliferating and differentiating 32D murine myeloid cells. J Cell Physiol 2006; 207:706-710 (Pubitemid 43668234)
14. Baserga R. Customizing the targeting of the IGF-1 Receptor. Future Oncology 2009a; in press.
15. Johnnidis JB, Harris MH, Wheeler RT, Stehling-Sun S, Lam MH, Kirak O, et al. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 2008; 451:(doi:10.1038/nature06607). (Pubitemid 351317447)
16. Valentinis B, Navarro M, Zanocco-Marani T, Edmonds P, McCormick J, Morrione A, et al. Insulin receptor substrate-1, p70S6K and cell size in transformation and differentiation of hemopoietic cells. J Biol Chem 2000; 275:25451-25459 (Pubitemid 30687045)
17. Belletti B, Prisco M, Morrione A, Valentinis B, Navarro M, Baserga R. Regulation of Id2 gene expression by the IGF-I receptor requires signaling by phosphatidylinositol-3 kinase. J Biol Chem 2001; 276:13867-13874
18. Prisco M, Peruzzi F, Belletti B, Baserga R. Regulation of Id gene expression by the type 1 insulin-like growth factor: roles of Stat3 and the tyrosine 950 residue of the receptor. Mol Cell Biol 2001; 21:5447-5458 (Pubitemid 32702449)
19. Valentinis B, Romano G, Peruzzi F, Morrione A, Prisco M, Soddu S, et al. Growth and differentiation signals by the insulin-like growth factor 1 receptor in hemopoietic cells are mediated through different pathways. J Biol Chem 1999; 274:12423-12430 (Pubitemid 129518006)
20. Sell C, Rubini M, Rubin R, Liu J-P, Efstratiadis A, Baserga R. Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type-1 IGF receptor. Proc Natl Acad Sci USA 1993; 90:11217-11221
21. Cui Q, Yu Z, Purisima EO, Wang E. Principles of microRNA regulation of a human cellular signling network. Mol Systems Biol 2006; doi:10.138/msb4100089. (Pubitemid 46061065)
22. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005; 433:769-773 (Pubitemid 40292988)
23. Chang Q, Li Y, White MF, Fletcher JA, Xiao S. Constitutive activation of insulin receptor substrate-1 is a frequent event in human tumors: therapeutic implications. Cancer Res 2002; 62:6035-6038 (Pubitemid 35244449)
24. Cristofanelli B, Valentinis B, Soddu S, Rizzo MG, Marchetti A, Bossi G, et al. Co-operative transformation of 32D cells by the combined expression of IRS-1 and v-Ha-Ras. Oncogene 2000; 19:3245-3255 (Pubitemid 30487411)
25. Morrison KB, Tognon CE, Garnett MJ, Deal C, Sorensen PHB. ETV6-NTRK3 transformation requires insulin-like growth factor 1 receptor signaling and is associated with constitutive IRS-1 tyrosine phosphorylation. Oncogene 2002; 21:5684-5695 (Pubitemid 35333001)
26. Lannon CL, Martin MJ, Tognon CE, Jin W, Kim SJ, Sorensen PHB. A highly consrved NTRK3 C-terminal sequence in the ETV6-NTRK3 oncoprotein binds the phosphotyrosine binding domain of insulin receptor substrate-1. J Biol Chem 2004; 279:6225-6234
27. Chen J, Wu A, Sun H, Drakas R, Garofalo C, Cascio S, et al. Functional significance of type 1 insulin-like growth factor-mediated nuclear translocation of the insulin receptor substrate-1 and β-catenin. J Biol Chem 2005; 280:29912-29920 (Pubitemid 41177069)
28. DeAngelis T, Chen J, Wu A, Prisco M, Baserga R. Transformation by the Simian Virus 40 T antigen is regulated by IGF-1 receptor and IRS-1 signaling. Oncogene 2006; 25:32-42. (Pubitemid 43050001)
29. Dearth RK, Cui X, Kim HJ, Kuiatse I, Lawrence NA, Zhang X, et al. Mammary tumorigenesis and metastasis caused by overexpression of the insulin receptor substrate-1 (IRS-1) or IRS-2. Mol Cell Biol 2006; 26. (Pubitemid 44904425)
30. Dalmizrak O, Wu A, Chen J, Sun H, Utama FE, Zambelli D, et al. The insulin receptor substrate-1 regulates the transformed phenotype of BT-20 human mammary cancer cells. Cancer Res 2007; 67:2124-2130 (Pubitemid 46424231)
31. Sun H, Baserga R. The role of insulin receptor substrate-1 in transformation by v-src. J Cell Physiol 2008; 215:725-732 (Pubitemid 351632694)
32. D'Ambrosio C, Keller SR, Morrione A, Lienhard GE, Baserga R, Surmacz E. Transforming potential of the insulin receptor substrate-1. Cell Growth & Diff 1995; 6:557-562
33. Del Rincon SV, Guo Q, Morelli C, Shiu HY, Surmacz E, Miller WH. Retinoic acid mediates degradation of IRS-1 by the ubiquitin-proteasome pathway, via a PKCdependent mechanism. Oncogene 2004; 23:9269-9279 (Pubitemid 40069697)
34. Cesarone G, Garofalo C, Abrams MT, Igoucheva O, Alexeev V, Yoon K, et al. RNAimediated silencing of insulin receptor substrate-1 (IRS-1) enhances tamoxifen-induced cell death in MCF-7 breast cancer cells. J Cell Biochem 2006; 98:440-450
35. Efstratiadis A. Genetics of mouse growth. Int J Dev Biol 1998; 42:955-959
36. Xu S-Q, Tang D, Chamberlain S, Pronk G, Masiarz FR, Kaur S, et al. The granulin/ epithelin precursor abrogates the requirement for the insulin-like growth factor I receptor for growth in vitro. J Biol Chem 1998; 272:20078-20083 (Pubitemid 28377561)
37. Bruning JC, Winnay J, Cheatham B, Kahn CR. Differential signaling by insulin receptor substrate-1 (IRS-1) and IRS-2 in IRS-1-deficient cells. Mol Cell Biol 1997; 17:1513-1521 (Pubitemid 27097381)